SE0202022D0 - Synergistic interaction of abacavir and alovudine - Google Patents

Synergistic interaction of abacavir and alovudine

Info

Publication number
SE0202022D0
SE0202022D0 SE0202022A SE0202022A SE0202022D0 SE 0202022 D0 SE0202022 D0 SE 0202022D0 SE 0202022 A SE0202022 A SE 0202022A SE 0202022 A SE0202022 A SE 0202022A SE 0202022 D0 SE0202022 D0 SE 0202022D0
Authority
SE
Sweden
Prior art keywords
alovudine
abacavir
synergistic interaction
synergistic
interaction
Prior art date
Application number
SE0202022A
Other languages
English (en)
Inventor
Goeran Maardh
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Priority to SE0202022A priority Critical patent/SE0202022D0/sv
Publication of SE0202022D0 publication Critical patent/SE0202022D0/sv
Priority to MXPA04012754A priority patent/MXPA04012754A/es
Priority to EP03733801A priority patent/EP1536800B1/en
Priority to CA002481890A priority patent/CA2481890A1/en
Priority to BR0311141-5A priority patent/BR0311141A/pt
Priority to ES03733801T priority patent/ES2254941T3/es
Priority to CNB038151685A priority patent/CN1302779C/zh
Priority to DE60303131T priority patent/DE60303131T2/de
Priority to PL03373758A priority patent/PL373758A1/xx
Priority to RU2005101874/15A priority patent/RU2320347C2/ru
Priority to AT03733801T priority patent/ATE314851T1/de
Priority to US10/519,332 priority patent/US20060084627A1/en
Priority to AU2003239088A priority patent/AU2003239088B2/en
Priority to KR10-2004-7021155A priority patent/KR20050013628A/ko
Priority to JP2004548906A priority patent/JP2005533870A/ja
Priority to PCT/SE2003/001100 priority patent/WO2004002433A1/en
Priority to NZ535817A priority patent/NZ535817A/en
Priority to ZA200408599A priority patent/ZA200408599B/en
Priority to IL16492104A priority patent/IL164921A0/xx
Priority to NO20050445A priority patent/NO20050445L/no
Priority to HK06100011.9A priority patent/HK1079981B/zh

Links

SE0202022A 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine SE0202022D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0202022A SE0202022D0 (sv) 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine
NZ535817A NZ535817A (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
PL03373758A PL373758A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
AT03733801T ATE314851T1 (de) 2002-06-27 2003-06-24 Synergistische wechselwirkung von abacavir und alovudin
CA002481890A CA2481890A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
BR0311141-5A BR0311141A (pt) 2002-06-27 2003-06-24 Interação sinergìstica de abacavir e alovudine
ES03733801T ES2254941T3 (es) 2002-06-27 2003-06-24 Interaccion sinergica entre abacavir y alovudina.
CNB038151685A CN1302779C (zh) 2002-06-27 2003-06-24 含有阿巴卡韦和阿洛夫定的药物制剂及其用途
DE60303131T DE60303131T2 (de) 2002-06-27 2003-06-24 Synergistische wechselwirkung von abacavir und alovudin
MXPA04012754A MXPA04012754A (es) 2002-06-27 2003-06-24 Interaccion sinergica de abacavir y alovudina.
RU2005101874/15A RU2320347C2 (ru) 2002-06-27 2003-06-24 Синергетическое взаимодействие абакавира и аловудина
EP03733801A EP1536800B1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
US10/519,332 US20060084627A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
AU2003239088A AU2003239088B2 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
KR10-2004-7021155A KR20050013628A (ko) 2002-06-27 2003-06-24 아바카비르와 알로부딘의 공동상승 상호작용
JP2004548906A JP2005533870A (ja) 2002-06-27 2003-06-24 アバカビールおよびアロブジンの相乗的相互作用
PCT/SE2003/001100 WO2004002433A1 (en) 2002-06-27 2003-06-24 Synergistic interaction of abacavir and alovudine
ZA200408599A ZA200408599B (en) 2002-06-27 2004-10-22 Synergistic interaction of abacavir and alovudine.
IL16492104A IL164921A0 (en) 2002-06-27 2004-10-28 Synergistic interaction of abacavir and alovudine
NO20050445A NO20050445L (no) 2002-06-27 2005-01-26 Synergistisk interaksjon mellom abacavir og alovudin
HK06100011.9A HK1079981B (zh) 2002-06-27 2006-01-03 含有阿巴卡韋和阿洛夫定的藥物製劑及其用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202022A SE0202022D0 (sv) 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine

Publications (1)

Publication Number Publication Date
SE0202022D0 true SE0202022D0 (sv) 2002-06-27

Family

ID=20288372

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202022A SE0202022D0 (sv) 2002-06-27 2002-06-27 Synergistic interaction of abacavir and alovudine

Country Status (2)

Country Link
SE (1) SE0202022D0 (sv)
ZA (1) ZA200408599B (sv)

Also Published As

Publication number Publication date
ZA200408599B (en) 2005-08-31

Similar Documents

Publication Publication Date Title
PL372814A1 (en) Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
DE50210454D1 (de) Einpark- und/oder Rangierhilfeeinrichtung
EE05516B1 (et) Indasoolid bensotiasoolid ja bensoisotiasoolid nende valmistamine ning kasutamine
IS7689A (is) Fjölþátta lyfjaskammtaform
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
IS7894A (is) Skammtaform með ofnæmisvaka
IL184735A0 (en) Pharmaceutical formulations and methods of use
AU2003259735A8 (en) Small-mer compositions and methods of use
IL183689A (en) Pharmaceutical compositions for improving the structure and function of arterioles
ATE390426T1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
FI20031190A (sv) Antioxidant och dess användning
DK1558595T3 (da) Piperazinyl- og diazapanylbenzamider og -benzthioamider
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1766092A4 (en) TARGET-SPECIFIC COMPOMERS AND METHOD OF USE
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
DE60318139D1 (de) Isolator- und Anordnungskonfiguration
DE60310092D1 (de) Gelförmiges wasch- und/oder vorbehandlungsmittel
FI20041220A0 (sv) Nytt lackasenzym och användning därav
IS8326A (is) Blandan af serótónín endurupptöku hindra og loxapíni
SE0202022D0 (sv) Synergistic interaction of abacavir and alovudine
FI20031458A (sv) Bärförpackning och packningens bärkonstruktion
DE50313181D1 (de) Alkyl-und/oder alkylenoligoglycosid-betainesterquats
DE50210561D1 (de) Sitz- und/oder liegemöbel
IL177751A0 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use
FI20031314A (sv) Fastsättningssystem och användning därav